CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
17 hedge funds and large institutions have $683K invested in Cyclo Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$30.7K | |
| 2 | +$18.3K | |
| 3 | +$15K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.54K |
| 5 |
JPMorgan Chase & Co
New York
|
+$341 |
Top Sellers
| 1 | -$28K | |
| 2 | -$5.68K | |
| 3 | -$4.04K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$525 |